Guidelines for disclosing genetic information to family members:: From development to use

被引:67
作者
Godard, B
Hurlimann, T
Letendre, M
Égalité, N
机构
[1] Univ Montreal, Program Bioeth, Montreal, PQ H3C 3J7, Canada
[2] Inst Rech Clin Montreal, Ctr Bioeth, Montreal, PQ H2W 1R7, Canada
[3] Eth Clin Res Inc, Eth & Govt Affairs, Montreal, PQ H9P 2VH, Canada
[4] Univ Montreal, Programmes Bioeth, Montreal, PQ H3C 3J7, Canada
基金
加拿大健康研究院;
关键词
disclosure; duty to warn; genetic testing; guidelines; recommendations; relatives;
D O I
10.1007/s10689-005-2581-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This paper presents the existing legal frameworks, professional guidelines and other documents related to the conditions and extent of the disclosure of genetic information by physicians to at-risk family members. Although the duty of a physician regarding disclosure of genetic information to a patient's relatives has only been addressed by few legal cases, courts have found such a duty under some circumstances. Generally, disclosure should not be permitted without the patient's consent. Yet, due to the nature of genetic information, exceptions are foreseen, where treatment and prevention are available. This duty to warn a patient's relative is also supported by some professional and policy organizations that have addressed the issue. Practice guidelines with a communication and intervention plan are emerging, providing physicians with tools that allow them to assist patients in their communication with relatives without jeopardizing their professional liability. Since guidelines aim to improve the appropriateness of medical practice and consequently to better serve the interests of patients, it is important to determine to what degree they document the 'best practice' standards. Such an analysis is an essential step to evaluate the different approaches permitting the disclosure of genetic information to family members.
引用
收藏
页码:103 / 116
页数:14
相关论文
共 59 条
[1]  
*AMA, 2003, E2131 AMA
[3]  
Beauchamp TL, 1994, Principles of biomedical ethics
[4]  
Bell D, 2001, Med Law Rev, V9, P130, DOI 10.1093/medlaw/9.2.130
[5]  
BOK S, 1988, ETHICAL ISSUES PROFE, P230
[6]  
Bottis M C, 2000, Eur J Health Law, V7, P173, DOI 10.1023/A:1008710225722
[7]  
*BREAST CANC WORK, 1998, J WOMENS HEALTH, V7, P531
[8]  
Burnett J W, 1999, Houst Law Rev, V36, P559
[9]  
Campbell A, 2001, McGill Law J, V46, P473
[10]   Genetic screening and ethics: European perspectives [J].
Chadwick, R ;
ten Have, H ;
Husted, J ;
Levitt, M ;
McGleenan, T ;
Shickle, D ;
Wiesing, U .
JOURNAL OF MEDICINE AND PHILOSOPHY, 1998, 23 (03) :255-273